DexCom, Inc. (DXCM)
63.23
+1.01
(+1.62%)
USD |
NASDAQ |
Apr 06, 16:00
63.00
-0.23
(-0.36%)
After-Hours: 19:28
DexCom Market Cap : 24.28B for April 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insulet Corp. | 14.14B |
| Abbott Laboratories | 178.58B |
| Intuitive Surgical, Inc. | 156.37B |
| Boston Scientific Corp. | 94.07B |
| Tandem Diabetes Care, Inc. | 1.297B |
Market Cap Related Metrics
| PE Ratio | 30.21 |
| PS Ratio | 5.500 |
| PEG Ratio | 0.6439 |
| Price to Book Value | 8.862 |
| Price to Free Cash Flow | 23.80 |
| Price | 63.23 |
| Earnings Yield | 3.31% |
| PEGY Ratio | 0.6439 |
| Operating PE Ratio | 28.12 |
| Normalized PE Ratio | 30.21 |